Cara Therapeutics Inc (NASDAQ:CARA)

29.18
Delayed Data
As of Apr 09
 +1.71 / +6.22%
Today’s Change
12.30
Today|||52-Week Range
29.65
+92.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues3.8M86.0K911.0K13.5M
 
 
 
 
 
Depreciation And Amortization839.0K1.5M495.0K370.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses28.2M57.0M59.9M90.5M
 
 
 
 
 
Research And Development20.8M48.4M48.1M75.2M
 
 
 
 
 
Total Operating Expenses29.0M58.5M60.4M90.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-25.2M-58.4M-59.5M-77.4M
 
 
 
 
 
Other Expenses0.0023.0K5.0K-5.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-25.1M-57.7M-58.3M-74.4M
 
 
 
 
 
Income Taxes-397.0K-468.0K-204.0K-389.0K
 
 
 
 
 
Net Income-24.7M-57.3M-58.1M-74.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS24.6M27.3M31.2M35.9M
 
 
 
 
 
Shares To Calculate EPS Diluted24.6M27.3M31.2M35.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.00-$2.10-$1.86-$2.06
 
 
 
 
 
EPS Diluted-$1.00-$2.10-$1.86-$2.06